Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection. - Gibb, D; Duong, T; Leclezio, V; Walker, A; Verweel, G; Dunn, D (Pediatric infectious disease journal, 2004)